Single dose of magic mushroom psychedelic can cause anatomical brain changes, study finds

A new study has found that a single dose of psilocybin, the psychoactive compound in magic mushrooms, can induce anatomical changes in the brain that persist for at least a month. Researchers observed these changes in healthy volunteers who had never previously taken psychedelics, noting increased density and robustness in certain nerve tracts. Participants also reported deeper psychological insight and improved wellbeing following the experience, suggesting a potential link between the brain alterations and positive mental health outcomes. The study involved 28 volunteers who initially received a placebo dose of 1mg psilocybin, followed by a 25mg dose a month later, sufficient to induce a strong psychedelic experience. Brain activity was monitored using electroencephalography (EEG), functional MRI, and diffusion tensor imaging (DTI). EEG data showed an immediate surge in brain entropy during the psychedelic experience, indicating heightened neural variability. A month after the dose, DTI scans revealed structural changes in nerve bundles, contrasting with the degeneration typically seen in aging and dementia. These findings contribute to a growing body of research exploring how psychedelics may promote mental flexibility and wellbeing, potentially offering new avenues for treating conditions such as anxiety, depression, and addiction. While the exact implications of the anatomical changes remain unclear, the study’s senior author, Professor Robin Carhart-Harris of the University of California, San Francisco, emphasized the significance of observing such brain alterations after a single drug dose. The research supports the hypothesis that psychedelics can induce lasting neuroplasticity, which may underlie their therapeutic effects. This study adds to the renewed scientific interest in psychedelics, which have historically been stigmatized but are now being reconsidered for their clinical potential. Further research is needed to understand the mechanisms behind these brain changes and their long-term impact on mental health. The results highlight the importance of controlled clinical settings to safely explore the benefits and risks of psychedelic substances.